MYRIAD GENETICS, INC. Capital Expenditures Incurred but Not yet Paid
MYRIAD GENETICS, INC. (MYGN) reported Capital Expenditures Incurred but Not yet Paid of $8.30 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2023-11-07
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-09-30 was $800.00K.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was -$500.00K, a 114.71% decline year-over-year.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $8.00M, a 788.89% increase year-over-year.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-12-31 was $5.70M.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $10.00M.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $0.00.
- MYRIAD GENETICS, INC. capital expenditures incurred but not yet paid for fiscal 2020 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2023-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $300.00K derived: sum of 2 quarters · filed 2023-11-07 | $8.30M 10-Q · filed 2023-11-07 | $14.00M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.50M 10-Q · filed 2023-08-04 | $13.20M derived: sum of 3 quarters · filed 2023-08-04 | $13.20M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | $8.00M 10-Q · filed 2023-05-04 | $13.70M derived: sum of 2 quarters · filed 2023-05-04 | $13.70M derived: sum of 3 quarters · filed 2023-11-07 | $17.10M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.70M derived: sum of 2 quarters · filed 2023-11-07 | $9.10M derived: sum of 3 quarters · filed 2023-11-07 | $10.00M 10-K · filed 2023-03-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.40M derived: sum of 2 quarters · filed 2023-11-07 | $4.30M 10-Q · filed 2023-11-07 | $4.30M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $4.30M 10-Q · filed 2023-08-04 | $4.30M derived: sum of 3 quarters · filed 2023-08-04 | $4.30M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $900.00K 10-Q · filed 2023-05-04 | $900.00K derived: sum of 2 quarters · filed 2023-05-04 | $900.00K derived: sum of 3 quarters · filed 2023-05-04 | $900.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-06-30 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |